Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01848327 · ClinicalTrials.gov registry record · NA
Caprylic Triglyceride for Treatment of Cognitive Impairments in Multiple Sclerosis
A NA study, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 124
- Enrollment target
NCT01848327 is a NA study that has completed, run by University of Miami. The registered enrollment target is 124 participants.
The verdict
NCT01848327, a NA study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 124 participants
- Enrollment target
Study Summary
Background/Rationale: Cognitive problems are a common symptom in individuals with Multiple Sclerosis (MS). Treatment options are limited, and there is a pressing need for new interventions to treat MS-related cognitive impairment. Glucose (a type of sugar) is used to fuel the cells of the healthy brain. For people with neurological conditions such as MS, glucose is not converted into energy as efficiently as it would be in a healthy brain, which can lead to a decrease in cognitive function. Caprylic Triglyceride may work to bypass this problem by providing an alternative energy source that is metabolized in the liver and used by the brain. Objective: To evaluate the therapeutic effects of 90 days of caprylic triglyceride on cognitive impairment in multiple sclerosis. Design: Randomized, double blinded, placebo controlled trial of 158 subjects. Outcome: Change in Total Learning (Trials 1-5) on the California Verbal Learning Test-2nd Edition-(CVLT-II) AND Change in Symbol Digit Modalities Test (SDMT) (at day 90
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Caprylic Triglyceride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2013-02 |
| Est. Completion | 2017-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01848327
The ClinicalTrials.gov registry entry for NCT01848327 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01848327 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01848327 about?
NCT01848327 is a clinical study titled "Caprylic Triglyceride for Treatment of Cognitive Impairments in Multiple Sclerosis". Background/Rationale: Cognitive problems are a common symptom in individuals with Multiple Sclerosis (MS). Treatment options are limited, and there is a pressing need for new interventions to treat MS-related cognitive impairment. Glucose (a type of sugar) is used to fuel the cells of the healthy br...
What is the current status of trial NCT01848327?
This trial is currently completed. It is a NA study. The enrollment target is 124 participants. The study started on 2013-02. Estimated completion is 2017-12.
What interventions are being tested in trial NCT01848327?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Caprylic Triglyceride (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01848327?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.